Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial

BACKGROUND: Currently, there are no medications approved for the treatment of juvenile fibromyalgia (JFM). We evaluated the safety and efficacy of duloxetine 30/60 mg once daily (QD) versus placebo in adolescents with JFM. METHODS: In this Phase 3b, multisite (US, Argentina, Puerto Rico, and India)...

Descripción completa

Detalles Bibliográficos
Autores principales: Upadhyaya, Himanshu P., Arnold, Lesley M., Alaka, Karla, Qiao, Meihua, Williams, David, Mehta, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540374/
https://www.ncbi.nlm.nih.gov/pubmed/31138224
http://dx.doi.org/10.1186/s12969-019-0325-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540374/
https://www.ncbi.nlm.nih.gov/pubmed/31138224
http://dx.doi.org/10.1186/s12969-019-0325-6

Ejemplares similares